Search

Sandra B Ogueta

from Newton, MA
Age ~61

Sandra Ogueta Phones & Addresses

  • 4 Nonantum St #2, Newton, MA 02458 (617) 969-4233
  • 4 Nonantum St, Newton, MA 02458
  • 94 Griggs Rd, Brookline, MA 02446 (978) 264-5512
  • 1440 Beacon St, Brookline, MA 02446 (617) 264-5512
  • 1624 Camden Ave, Los Angeles, CA 90025 (310) 478-1153
  • Brighton, MA

Work

Company: Novartis institutes for biomedical research Nov 2012 Address: Cambridge, MA Position: Head of operations and project management

Education

School / High School: Boston University 2010

Industries

Pharmaceuticals

Resumes

Resumes

Sandra Ogueta Photo 1

Head Of Operations And Project Management At Novartis Institutes For Biomedical Research

View page
Position:
Head of Operations and Project Management at Novartis Institutes for BioMedical Research
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Work:
Novartis Institutes for BioMedical Research - Cambridge, MA since Nov 2012
Head of Operations and Project Management

Novartis Institutes for Biomedical Research Dec 2010 - Nov 2012
Associate Director, Research Project Management

Molecular Insight Pharmaceuticals Aug 2007 - Dec 2010
Associate Director, Program and Alliance Management

Shire Pharmaceuticals Aug 2006 - Aug 2007
Quality Control Manager and Project Lead, Cell Biology

Therion Biologics Aug 2001 - Jul 2006
Quality Technical Support/ CMC Project Manager
Education:
Boston University 2010
Universidad de Buenos Aires 1989 - 1993
Universidad de Buenos Aires 1981 - 1989
Universidad de Buenos Aires 1981 - 1987

Publications

Us Patents

Pseudotyped Lentiviral Vectors And Uses Thereof

View page
US Patent:
7078031, Jul 18, 2006
Filed:
May 13, 2004
Appl. No.:
10/844873
Inventors:
Wayne A. Marasco - Wellesley MA, US
Sandra Ogueta - Brookline MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 48/00
C12N 15/867
C12N 15/63
C12N 15/64
US Classification:
424 932, 424 931, 424 936, 4353201, 435455, 435456
Abstract:
A vector system that will produce a pseudotyped lentiviral vector that can be used to deliver a desired gene is disclosed. The vector constructs that are described include a number of modifications that enhance the safety of the vector. The vector can be used to more specifically target cells for expression of certain genes.

Pseudotyped Lentiviral Vectors And Uses Thereof

View page
US Patent:
7262049, Aug 28, 2007
Filed:
Sep 14, 2001
Appl. No.:
09/953344
Inventors:
Wayne A Marasco - Wellesley MA, US
Sandra Ogueta - Brookline MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C12N 15/867
C12N 15/49
A61K 48/00
US Classification:
4353201, 536 231, 536 2372
Abstract:
A vector system that will produce a pseudotyped lentiviral vector that can be used to deliver a desired gene is disclosed. The vector constructs that are described include a number of modifications that enhance the safety of the vector. The vector can be used to more specifically target cells for expression of certain genes.

Lentiviral Vector System For High Quantity Screening

View page
US Patent:
20020155430, Oct 24, 2002
Filed:
Sep 14, 2001
Appl. No.:
09/953343
Inventors:
Wayne Marsco - Wellesley MA, US
Sandra Ogueta - Brookline MA, US
Assignee:
Dana-Farber Cancer Institute, Inc.
International Classification:
C12Q001/70
C12Q001/68
C12N015/867
US Classification:
435/005000, 435/006000, 435/456000
Abstract:
A method of screening for a target molecule from a group of potential target molecules is described. This method involves using a library of lentiviral vectors where the members encode the group of target molecules, then transducing a group of cells and screening the transduced cell for a desired phenotype. The cell(s) displaying the desired phenotype is selected and the target molecule is identified.
Sandra B Ogueta from Newton, MA, age ~61 Get Report